On Sunday at the AUA conference there was a poster (#159) titled ADJUVANT VS. SALVAGE RADIATION THERAPY FOLLOWING PROSTATECTOMY FOR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM SEER-MEDICARE written by Keith J. Kowalczyk, etal. The researchers evaluated the optimal timing of external beam radiation (RT) after the completion of a radical prostatectomy (RP) as primary treatment [...]
Currently the American Urologic Association is holding their annual conference. Like the ASCO and AACR conferences there are many presentations and posters given that harkens the latest in research findings for general urological topics as well as for prostate cancer. I will be reporting on a number of these findings over the next period of [...]
One of the largest and most controversial issues for the treatment of advanced prostate cancer is the value of androgen-deprivation therapy (ADT). Most doctors use ADT as their pivotal initial treatment in the management of locally advanced and metastatic prostate cancer (PCa). But, the grand question is does it extend survival? […]
